Wuhan Keqian Biology Discloses Investment in DEKON AGR's Hong Kong IPO

Deep News

Feb 11

Wuhan Keqian Biology Co.,Ltd. stated on an investor interactive platform that it participated as an investor in the Hong Kong Stock Exchange IPO of Sichuan DEKON AGR at the end of 2023. The company clarified that the investment in DEKON AGR was made to strengthen communication and collaboration with a key client, rather than for short-term selling, repurchasing, or investment returns. Consequently, the investment has been classified as a financial asset measured at fair value through other comprehensive income and is reported under other equity instrument investments. For detailed information, refer to the "Notes to Consolidated Financial Statement Items – 18. Other Equity Instrument Investments" section in the company’s periodic financial reports.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1115366674"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115366674\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115366674?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-11 21:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115366674","market":"fut","top_or_hot":-1,"title":"Wuhan Keqian Biology Discloses Investment in DEKON AGR's Hong Kong IPO","media":"Deep News","content":"<p>Wuhan Keqian Biology Co.,Ltd. stated on an investor interactive platform that it participated as an investor in the Hong Kong Stock Exchange IPO of Sichuan DEKON AGR at the end of 2023. The company clarified that the investment in DEKON AGR was made to strengthen communication and collaboration with a key client, rather than for short-term selling, repurchasing, or investment returns. Consequently, the investment has been classified as a financial asset measured at fair value through other comprehensive income and is reported under other equity instrument investments. For detailed information, refer to the \"Notes to Consolidated Financial Statement Items – 18. Other Equity Instrument Investments\" section in the company’s periodic financial reports.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wuhan Keqian Biology Discloses Investment in DEKON AGR's Hong Kong IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuhan Keqian Biology Discloses Investment in DEKON AGR's Hong Kong IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-02-11 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wuhan Keqian Biology Co.,Ltd. stated on an investor interactive platform that it participated as an investor in the Hong Kong Stock Exchange IPO of Sichuan DEKON AGR at the end of 2023. The company clarified that the investment in DEKON AGR was made to strengthen communication and collaboration with a key client, rather than for short-term selling, repurchasing, or investment returns. Consequently, the investment has been classified as a financial asset measured at fair value through other comprehensive income and is reported under other equity instrument investments. For detailed information, refer to the \"Notes to Consolidated Financial Statement Items – 18. Other Equity Instrument Investments\" section in the company’s periodic financial reports.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1237","symbol_name":"包装食品与肉类","start_time":0,"source_url":"","article_id":"1115366674","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115366674","pubTimestamp":1770816639,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Wuhan Keqian Biology Co.,Ltd. stated on an investor interactive platform that it participated as an investor in the Hong Kong Stock Exchange IPO of Sichuan DEKON AGR at the end of 2023. The company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159151":"食品","688526":"科前生物","BK1237":"包装食品与肉类","02419":"德康农牧","BK0239":"医药制造"},"translate_title":"武汉科前生物披露投资德康AGR香港IPO","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159151":1,"688526":1,"02419":1,"HEXmain":1},"content_text":"Wuhan Keqian Biology Co.,Ltd. stated on an investor interactive platform that it participated as an investor in the Hong Kong Stock Exchange IPO of Sichuan DEKON AGR at the end of 2023. The company clarified that the investment in DEKON AGR was made to strengthen communication and collaboration with a key client, rather than for short-term selling, repurchasing, or investment returns. Consequently, the investment has been classified as a financial asset measured at fair value through other comprehensive income and is reported under other equity instrument investments. For detailed information, refer to the \"Notes to Consolidated Financial Statement Items – 18. Other Equity Instrument Investments\" section in the company’s periodic financial reports.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}